
Major depressive disorders: clinical efficacy and tolerability of agomelatine, a new melatonergic agonist
Keywords: اختلال افسردگی عمده; Major depressive disorder; Agomelatine; Melatonergic agonist; Paroxetine; Venlafaxine; Severe depression; Sexual dysfunction; Daytime alertness; Discontinuation syndrome